Core Viewpoint - COSCO SHIPPING Holdings Co., Ltd. has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][4]. Earnings Estimates and Ratings - The Zacks rating system is based solely on a company's changing earnings picture, tracking the Zacks Consensus Estimate for EPS from sell-side analysts [2]. - The Zacks rating upgrade for China Cosco reflects an optimistic earnings outlook, likely leading to increased buying pressure and a rise in stock price [4][6]. Impact of Earnings Estimates on Stock Prices - Changes in a company's future earnings potential, as shown by earnings estimate revisions, are strongly correlated with near-term stock price movements, influenced by institutional investors [5]. - Rising earnings estimates for China Cosco indicate an improvement in the company's underlying business, which should drive the stock price higher [6]. Importance of Earnings Estimate Revisions - Empirical research supports a strong correlation between earnings estimate revisions and near-term stock movements, making it beneficial to track these revisions for investment decisions [7]. - The Zacks Rank stock-rating system effectively utilizes earnings estimate revisions to classify stocks into five groups, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [8]. Specific Earnings Estimates for China Cosco - For the fiscal year ending December 2025, China Cosco is expected to earn $1.31 per share, unchanged from the previous year, but the Zacks Consensus Estimate has increased by 7% over the past three months [9]. Conclusion on Zacks Rating System - The Zacks rating system maintains a balanced proportion of "buy" and "sell" ratings across its universe of over 4,000 stocks, with only the top 5% receiving a "Strong Buy" rating [10]. - The upgrade of China Cosco to Zacks Rank 1 places it in the top 5% of stocks based on estimate revisions, suggesting potential for market-beating returns in the near term [11].

Equity Bancshares (EQBK) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Since a changin ...

Samsara Inc. (IOT) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Since a changing earni ...

Group 1 - StepStone Group Inc. (STEP) shares increased by 6% to close at $63.24, with a notable trading volume compared to normal sessions, and an overall gain of 11.3% over the past four weeks [1][2] - The price surge was driven by the announcement that StepStone is leveraging Goji's technology to improve access to its European private market evergreen funds, enhancing the investor experience [2] - The company is projected to report quarterly earnings of $0.41 per share, reflecting a year-over-year decline of 14.6%, while revenues are expected to reach $228.81 million, a 3.5% increase from the previous year [3] Group 2 - The consensus EPS estimate for StepStone has remained stable over the last 30 days, indicating that stock price movements may not sustain without earnings estimate revisions [4] - StepStone Group holds a Zacks Rank of 1 (Strong Buy), suggesting strong market confidence in the stock's potential [4] - The company operates within the Zacks Financial - Miscellaneous Services industry, which includes other firms like Houlihan Lokey, whose stock has also shown positive performance [4][5]

American Express (AXP) came out with quarterly earnings of $4.08 per share, beating the Zacks Consensus Estimate of $3.86 per share. This compares to earnings of $3.49 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +5.70%. A quarter ago, it was expected that this credit card issuer and global payments company would post earnings of $3.45 per share when it actually produced earnings of $3.64, delivering a surprise of +5.51%.Ov ...

Ambac Financial Group (AMBC) shares soared 17.7% in the last trading session to close at $8.65. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 6.2% gain over the past four weeks.Ambac shares surged after the Wisconsin Office of the Commissioner of Insurance scheduled a hearing on the sale of Ambac Assurance Corporation. This is considered one of the final steps in the Wisconsin regulatory approval process. Ambac's president and ...

New Gold (NGD) has been beaten down lately with too much selling pressure. While the stock has lost 10% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier.We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price mov ...

Core Insights - Chipotle Mexican Grill (CMG) is expected to report quarterly earnings of $0.32 per share, reflecting a 5.9% decline year-over-year, while revenues are forecasted to reach $3.1 billion, indicating a 4.4% increase compared to the previous year [1] Earnings Estimates - The consensus EPS estimate has been revised downward by 0.4% over the past 30 days, indicating a collective reassessment by analysts [2] - Revisions to earnings estimates are crucial for predicting investor actions, as empirical research shows a strong correlation between earnings estimate trends and short-term stock price performance [3] Revenue Metrics - Analysts estimate 'Revenue- Food and beverage' to be $3.08 billion, representing a 4.2% year-over-year increase [5] - The forecast for 'Revenue- Delivery service' is $16.06 million, which reflects an 11.8% decline from the same quarter last year [5] Restaurant Operations - The estimated number of 'Company-operated restaurants at end of period' is 3,846, up from 3,530 in the same quarter last year [6] - Analysts predict a 'Comparable restaurant sales increase' of -2.8%, a significant drop from the previous year's 11.1% [6] New Openings and Sales - The consensus is that 'Company-operated restaurants opened' will total 65, compared to 52 in the prior year [7] - The projected 'Company-operated restaurants at beginning of period' is 3,781, up from 3,479 in the same quarter last year [7] - The estimated 'Average restaurant sales - TTM' is $3.14 million, slightly down from $3.15 million year-over-year [7] Stock Performance - Over the past month, Chipotle shares have returned +3.3%, while the Zacks S&P 500 composite has seen a +5.4% change [8] - CMG currently holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [8]

Core Viewpoint - Boston Scientific (BSX) is expected to report quarterly earnings of $0.72 per share, reflecting a 16.1% increase year-over-year, with revenues projected at $4.89 billion, an 18.7% increase compared to the previous year [1]. Financial Performance Estimates - Analysts anticipate 'Net Sales- MedSurg- Worldwide' to reach $1.68 billion, indicating a 13.1% increase from the prior-year quarter [4]. - The estimated 'Net Sales- Cardiovascular- Worldwide' is projected at $3.21 billion, representing a 21.7% increase year-over-year [4]. - 'Net Sales- Cardiovascular- Cardiology- Worldwide' is expected to be $2.52 billion, showing a 23.3% increase from the previous year [5]. - 'Net Sales- Cardiovascular- Peripheral Interventions- Worldwide' is forecasted at $689.56 million, indicating a 16.9% year-over-year change [5]. - 'Geographic Revenue- U.S.' is likely to reach $3.06 billion, reflecting a 24.1% increase year-over-year [6]. - 'Net Sales- Cardiovascular- Peripheral Interventions- International' is projected at $309.92 million, indicating a 10.3% increase from the prior year [6]. - 'Net Sales- MedSurg- Neuromodulation- United States' is expected to be $220.82 million, showing a 3.2% increase year-over-year [7]. - 'Net Sales- MedSurg- Neuromodulation- International' is forecasted at $70.31 million, reflecting a 3.4% increase [7]. - 'Net Sales- MedSurg- Endoscopy- United States' is projected at $445.09 million, indicating a 7.3% increase year-over-year [8]. - 'Net Sales- MedSurg- Endoscopy- International' is expected to reach $273.79 million, reflecting a 4.9% increase [8]. - 'Net Sales- MedSurg- Urology- United States' is forecasted at $492.40 million, indicating a significant 35.7% increase year-over-year [8]. - 'Net Sales- MedSurg- Urology- International' is projected at $177.83 million, reflecting a 9.8% increase [9]. Market Performance - Over the past month, shares of Boston Scientific have returned +3.2%, compared to the Zacks S&P 500 composite's +5.4% change [9]. - Currently, BSX holds a Zacks Rank 2 (Buy), suggesting potential outperformance in the near future [9].

Core Insights - Hasbro (HAS) is expected to report quarterly earnings of $0.76 per share, reflecting a 37.7% decline year-over-year, with revenues forecasted at $872.98 million, down 12.3% from the previous year [1] Earnings Estimates - Over the last 30 days, the consensus EPS estimate has been revised upward by 1.1%, indicating analysts' reassessment of their initial forecasts [2] - Prior to earnings releases, revisions to earnings projections are crucial for predicting investor behavior, as studies show a strong correlation between earnings estimate trends and short-term stock performance [3] Revenue Forecasts - Analysts estimate 'External Net Revenues- Entertainment' at $19.18 million, a 2% increase year-over-year [5] - 'External Net Revenues- Consumer Products' is projected to be $413.93 million, reflecting a 21.1% decrease from the prior-year quarter [5] - 'External Net Revenues- Wizards of the Coast and Digital Gaming' is expected to reach $459.57 million, indicating a 1.7% increase year-over-year [6] - The consensus for 'Wizards of the Coast and Digital Gaming Net Revenues- Tabletop Gaming' stands at $337.95 million, showing a 9.9% increase from the previous year [6] - 'Wizards of the Coast and Digital Gaming Net Revenues- Digital and Licensed Gaming' is estimated at $124.14 million, a 14% decline from the prior-year quarter [7] Operating Profit - Analysts project 'Operating profit (loss)- Wizards of the Coast and Digital Gaming' to be $185.99 million, down from $247.10 million in the previous year [7] Stock Performance - Over the past month, Hasbro shares have increased by 13.6%, outperforming the Zacks S&P 500 composite, which rose by 5.4% [7] - Currently, Hasbro holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [7]